Bio-Rad Laboratories Inc. (BIO)
Market Closed
1 Sep, 20:00
$
380. 96
-5.16
-1.3364%
$
10.44B Market Cap
- P/E Ratio
- Div Yield
256,107 Volume
11.51 Eps
$ 386.12
Previous Close 
Want to track BIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bio-Rad Laboratories Inc. (BIO) Statistics
Valuation metrics
Market Cap 10.44B
Enterprise value 11.12B
Trailing P/E (ttm) 46.54
Forward P/E 24.99
PEG ratio -0.16
Price/Sales (ttm) 4.03
Price/Book (mrq) 1.45
Enterprise Value/Revenue 4.3
Enterprise Value/EBITDA 20.8
Overview
Shares outstanding 26.83M
Float 20.9M
Shares short 34
% Held by insiders 0.16%
% Held by institutions 0.9%
Average volume (10 days) 484.56K
Average volume (90 days) 318.84K
Price summary
52-Week low 236.73
52-Week high 396.23
Beta 1.06
50-Day moving average 325.82
200-Day moving average 284.86
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio 0.22
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 8 Mar 2002
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.09%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.03%
Income Statement
Revenue (ttm) 2.59B
Revenue per share (ttm) 96.81
Quarterly revenue growth (yoy) 0.01%
Gross profit (ttm) 1.35B
EBITDA 478.9M
Net income to common (ttm) 168.8M
Diluted EPS (ttm) 8.32
Quarterly earnings growth (yoy) 0.01%
Balance Sheet
Total cash (mrq) 1.56B
Total cash per share (mrq) 60.51
Total debt (mrq) 1.38B
Total Debt/Equity (mrq) 0.17
Current ratio (mrq) 3.14%
Book value per share (mrq) 268.22
Cash Flow
Cash flow statement 510.4M
Levered free cash flow (LFCF) 229.76M
